Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk

Atherosclerosis

Volumn 197, Issue 2, 2008, Pages 757-767

  Pirro, Matteo ^a   Schillaci, Giuseppe ^a   Bagaglia, Francesco ^a   Menecali, Cinzia ^a   Paltriccia, Rita ^a   Mannarino, Massimo R ^a   Capanni, Marusca ^b   Velardi, Andrea ^b   Mannarino, Elmo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Arterial stiffness; Cardiovascular risk factors; Endothelial progenitor cells; Microparticles

Indexed keywords

ADULT; ARTERIAL STIFFNESS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CD34 SELECTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; STEM CELL;

ADULT; ANTIGENS, CD34; APOPTOSIS; BLOOD PRESSURE; CAROTID ARTERIES; CASE-CONTROL STUDIES; CELL COUNT; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; FEMORAL ARTERY; FLOW CYTOMETRY; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MANOMETRY; MIDDLE AGED; PARTICLE SIZE; PULSATILE FLOW; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 40949106784     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.07.012     Document Type: Article

References (49)

1. Gulati R., Lerman A., and Simari R.D. Therapeutic uses of autologous endothelial cells for vascular disease. Clin Sci (London) 109 (2005) 27-37
2. Werner N., Junk S., Laufs U., et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93 (2003) e17-e24
3. Powell T.M., Paul J.D., Hill J.M., et al. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 25 (2005) 296-301
4. Urao N., Okigaki M., Yamada H., et al. Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ Res 98 (2006) 1405-1413
5. Yoshioka T., Takahashi M., Shiba Y., et al. Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice. Cardiovasc Res 70 (2006) 61-69
6. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89 (2001) e1-e7
7. Werner N., and Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy?. Arterioscler Thromb Vasc Biol 26 (2006) 257-266
8. Fadini G.P., Miorin M., Facco M., et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 45 (2005) 1449-1457
9. Heiss C., Keymel S., Niesler U., et al. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 45 (2005) 1441-1448
10. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 340 (1999) 115-126
11. Imanishi T., Moriwaki C., Hano T., and Nishio I. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J Hypertens 23 (2005) 1831-1837
12. Kondo T., Hayashi M., Takeshita K., et al. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 24 (2004) 1442-1447
13. Pirro M., Schillaci G., Paltriccia R., et al. Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arterioscler Thromb Vasc Biol 26 (2006) 2530-2535
14. Thum T., Tsikas D., Stein S., et al. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol 46 (2005) 1693-1701
15. Thum T., and Bauersachs J. Spotlight on endothelial progenitor cell inhibitors: short review. Vasc Med 10 (2005) 59-64
16. Seeger F.H., Haendeler J., Walter D.H., et al. Dimmeler S. p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 111 (2005) 1184-1191
17. Jimenez J.J., Jy W., Mauro L.M., et al. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 109 (2003) 175-180
18. Jimenez J.J., Jy W., Mauro L.M., et al. Endothelial microparticles (EMP) as vascular disease markers. Adv Clin Chem 39 (2005) 131-157
19. Koga H., Sugiyama S., Kugiyama K., et al. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 45 (2005) 1622-1630
20. Preston R.A., Jy W., Jimenez J.J., et al. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 41 (2003) 211-217
21. Boulanger C.M., Scoazec A., Ebrahimian T., et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104 (2001) 2649-2652
22. Amabile N., Guerin A.P., Leroyer A., et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 16 (2005) 3381-3388
23. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486-97.
24. Pirro M., Schillaci G., Savarese G., et al. Attenuation of inflammation with short-term dietary intervention is associated with a reduction of arterial stiffness in subjects with hypercholesterolaemia. Eur J Cardiovasc Prev Rehabil 11 (2004) 497-502
25. Werner N., and Nickenig G. Clinical and therapeutical implications of EPC biology in atherosclerosis. J Cell Mol Med 10 (2006) 318-332
26. Pirro M., Schillaci G., Savarese G., et al. Low-grade systemic inflammation impairs arterial stiffness in newly diagnosed hypercholesterolaemia. Eur J Clin Invest 34 (2004) 335-341
27. Schillaci G., Pirro M., Vaudo G., et al. Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension. Hypertension 45 (2005) 1078-1082
28. Laurent S., Boutouyrie P., and Lacolley P. Structural and genetic bases of arterial stiffness. Hypertension 45 (2005) 1050-1055
29. Blacher J., Safar M.E., Pannier B., et al. Prognostic significance of arterial stiffness measurements in end-stage renal disease patients. Curr Opin Nephrol Hypertens 11 (2002) 629-634
30. Blacher J., and Safar M.E. Large-artery stiffness, hypertension and cardiovascular risk in older patients. Nat Clin Pract Cardiovasc Med 2 (2005) 450-455
31. Tao J., Wang Y., Yang Z., et al. Circulating endothelial progenitor cell deficiency contributes to impaired arterial elasticity in persons of advancing age. J Hum Hypertens 20 (2006) 490-495
32. Schwartzenberg S., Deutsch V., Maysel-Auslender S., et al. Circulating apoptotic progenitor cells: a novel biomarker in patients with acute coronary syndromes. Arterioscler Thromb Vasc Biol 27 (2007) e27-e31
33. Edelberg J.M., Tang L., Hattori K., Lyden D., and Rafii S. Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ Res 90 (2002) e89-e93
34. Scheubel R.J., Zorn H., Silber R.E., et al. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 42 (2003) 2073-2080
35. Aicher A., Heeschen C., Mildner-Rihm C., et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9 (2003) 1370-1376
36. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348 (2003) 593-600
37. Tepper O.M., Galiano R.D., Capla J.M., et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106 (2002) 2781-2786
38. Xu Q., Zhang Z., Davison F., and Hu Y. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice. Circ Res 93 (2003) e76-e86
39. Rauscher F.M., Goldschmidt-Clermont P.J., Davis B.H., et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108 (2003) 457-463
40. Schmidt-Lucke C., Rossig L., Fichtlscherer S., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111 (2005) 2981-2987
41. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 (2005) 999-1007
42. Kawashima S., and Yokoyama M. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol 24 (2004) 998-1005
43. Kinlay S., Creager M.A., Fukumoto M., et al. Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo. Hypertension 38 (2001) 1049-1053
44. Blann A.D., and Pretorius A. Circulating endothelial cells and endothelial progenitor cells: two sides of the same coin, or two different coins?. Atherosclerosis 188 (2006) 12-18
45. Zhang H., Vakil V., Braunstein M., et al. Circulating endothelial progenitor cells in multiple myeloma: implications and significance. Blood 105 (2005) 3286-3294
46. Makin A.J., Blann A.D., Chung N.A., Silverman S.H., and Lip G.Y. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor. Eur Heart J 25 (2004) 371-376
47. Wu H., Yao Q., Lumsden A., and Chen C. Characterization of two populations of human coronary artery endothelial cells. J Surg Res 118 (2004) 38-44
48. Peichev M., Naiyer A.J., Pereira D., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
49. Gehling U.M., Ergun S., Schumacher U., et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95 (2000) 3106-3112